IBDEI270 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,35019,0)
 ;;=M48.061^^137^1791^47
 ;;^UTILITY(U,$J,358.3,35019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35019,1,3,0)
 ;;=3^Spinal Stenosis,Lumbar Region w/o Neurogenic Claudication
 ;;^UTILITY(U,$J,358.3,35019,1,4,0)
 ;;=4^M48.061
 ;;^UTILITY(U,$J,358.3,35019,2)
 ;;=^5151513
 ;;^UTILITY(U,$J,358.3,35020,0)
 ;;=M48.062^^137^1791^46
 ;;^UTILITY(U,$J,358.3,35020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35020,1,3,0)
 ;;=3^Spinal Stenosis,Lumbar Region w/ Neurogenic Claudication
 ;;^UTILITY(U,$J,358.3,35020,1,4,0)
 ;;=4^M48.062
 ;;^UTILITY(U,$J,358.3,35020,2)
 ;;=^5151514
 ;;^UTILITY(U,$J,358.3,35021,0)
 ;;=M41.9^^137^1791^38
 ;;^UTILITY(U,$J,358.3,35021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35021,1,3,0)
 ;;=3^Scoliosis,Idiopathic
 ;;^UTILITY(U,$J,358.3,35021,1,4,0)
 ;;=4^M41.9
 ;;^UTILITY(U,$J,358.3,35021,2)
 ;;=^5011889
 ;;^UTILITY(U,$J,358.3,35022,0)
 ;;=R47.01^^137^1792^1
 ;;^UTILITY(U,$J,358.3,35022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35022,1,3,0)
 ;;=3^Aphasia
 ;;^UTILITY(U,$J,358.3,35022,1,4,0)
 ;;=4^R47.01
 ;;^UTILITY(U,$J,358.3,35022,2)
 ;;=^5019488
 ;;^UTILITY(U,$J,358.3,35023,0)
 ;;=I69.920^^137^1792^2
 ;;^UTILITY(U,$J,358.3,35023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35023,1,3,0)
 ;;=3^Aphasia after unspec cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,35023,1,4,0)
 ;;=4^I69.920
 ;;^UTILITY(U,$J,358.3,35023,2)
 ;;=^5007553
 ;;^UTILITY(U,$J,358.3,35024,0)
 ;;=I69.991^^137^1792^4
 ;;^UTILITY(U,$J,358.3,35024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35024,1,3,0)
 ;;=3^Dysphagia after unspec cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,35024,1,4,0)
 ;;=4^I69.991
 ;;^UTILITY(U,$J,358.3,35024,2)
 ;;=^5007569
 ;;^UTILITY(U,$J,358.3,35025,0)
 ;;=G11.1^^137^1792^5
 ;;^UTILITY(U,$J,358.3,35025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35025,1,3,0)
 ;;=3^Early-onset cerebellar ataxia
 ;;^UTILITY(U,$J,358.3,35025,1,4,0)
 ;;=4^G11.1
 ;;^UTILITY(U,$J,358.3,35025,2)
 ;;=^5003753
 ;;^UTILITY(U,$J,358.3,35026,0)
 ;;=I69.952^^137^1792^10
 ;;^UTILITY(U,$J,358.3,35026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35026,1,3,0)
 ;;=3^Hemiplegia after Unsp Crbvasc Dis,Left Dominant Side
 ;;^UTILITY(U,$J,358.3,35026,1,4,0)
 ;;=4^I69.952
 ;;^UTILITY(U,$J,358.3,35026,2)
 ;;=^5133586
 ;;^UTILITY(U,$J,358.3,35027,0)
 ;;=I69.954^^137^1792^11
 ;;^UTILITY(U,$J,358.3,35027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35027,1,3,0)
 ;;=3^Hemiplegia after Unsp Crbvasc Dis,Left Nondominant Side
 ;;^UTILITY(U,$J,358.3,35027,1,4,0)
 ;;=4^I69.954
 ;;^UTILITY(U,$J,358.3,35027,2)
 ;;=^5133587
 ;;^UTILITY(U,$J,358.3,35028,0)
 ;;=I69.951^^137^1792^12
 ;;^UTILITY(U,$J,358.3,35028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35028,1,3,0)
 ;;=3^Hemiplegia after Unsp Crbvasc Dis,Right Dominant Side
 ;;^UTILITY(U,$J,358.3,35028,1,4,0)
 ;;=4^I69.951
 ;;^UTILITY(U,$J,358.3,35028,2)
 ;;=^5007561
 ;;^UTILITY(U,$J,358.3,35029,0)
 ;;=I69.953^^137^1792^13
 ;;^UTILITY(U,$J,358.3,35029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35029,1,3,0)
 ;;=3^Hemiplegia after Unsp Crbvasc Dis,Right Nondominant Side
 ;;^UTILITY(U,$J,358.3,35029,1,4,0)
 ;;=4^I69.953
 ;;^UTILITY(U,$J,358.3,35029,2)
 ;;=^5007562
 ;;^UTILITY(U,$J,358.3,35030,0)
 ;;=G81.92^^137^1792^6
 ;;^UTILITY(U,$J,358.3,35030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35030,1,3,0)
 ;;=3^Hemiplegia,Unspec Affecting Left Dominant Side
